Baitouweng Decoction for ulcerative colitis with damp-heat
Part of Digestive system clinical trials.
This trial tests a traditional Chinese herbal formula called Baitouweng Decoction for people with mild to moderate ulcerative colitis who also have a specific pattern of symptoms called 'damp-heat' in the large intestine. It aims to see if the medicine can help reduce inflammation and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ulcerative colitis (a type of inflammatory bowel disease).
- Your disease is mild to moderate active (Mayo score between 3 and 8).
- You have symptoms of 'damp-heat' in the large intestine according to traditional Chinese medicine — like diarrhea with mucus or blood, belly pain, or feeling like you need to go often.
- You can tolerate the herbal medicine Baitouweng Decoction.
- You are able to have a colonoscopy and a related procedure (TET) if needed.
- You are willing to join the study and follow the process.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether acupuncture can help reduce symptoms like diarrhea and blood in stool for people with mild to moderate ulcerative colitis. It is a non-drug treatment that may be added to your usual therapy with mesalamine.
This study tests a new drug called duvakitug for people with moderate to severe ulcerative colitis that hasn't been helped enough by standard treatments. The goal is to see if this medicine can reduce inflammation and improve symptoms.
This study is looking at how well the drug upadacitinib works and how safe it is for Chinese adults with moderate to severe ulcerative colitis. It is not a treatment trial, but will observe patients who are already taking upadacitinib as decided by their doctor.
This study tests an experimental drug called HSK47388 for people with moderate to severe ulcerative colitis who have not had good results from other treatments. The goal is to see if it can reduce inflammation and improve symptoms.
This trial tests a new medicine (TQH3906) for people with moderate to severe ulcerative colitis or Crohn's disease that hasn't improved with other treatments. The goal is to see if it can help control inflammation in the gut.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.